Advancing hemostasis: A meta-analysis of novel <i>vs</i> conventional endoscopic therapies for non variceal upper gastrointestinal bleeding.

In the tumor-related bleeding subgroup, OTSC was associated with a significant reduction in short-term rebleeding (RR: 0.47; 95%CI: 0.237-0.934; P = 0.0312) and 30-day mortality (RR: 0.361; 95%CI: 0.173-0.753; P = 0.0066), whereas other outcomes did not reach statistical significance.

also in 111,027 other papers